{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:11:55Z","timestamp":1782918715787,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011841","name":"Xinxiang Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["202210472011"],"award-info":[{"award-number":["202210472011"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["222102310016"],"award-info":[{"award-number":["222102310016"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["231111311300"],"award-info":[{"award-number":["231111311300"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111362","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T18:09:07Z","timestamp":1702663747000},"page":"111362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Plasmid co-expressing siRNA-PD-1 and Endostatin carried by attenuated Salmonella enhanced the anti-melanoma effect via inhibiting the expression of PD-1 and VEGF on tumor-bearing mice"],"prefix":"10.1016","volume":"127","author":[{"given":"Tian","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunge","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8809-4433","authenticated-orcid":false,"given":"Ying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-1978","authenticated-orcid":false,"given":"Tiesuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.intimp.2023.111362_b0005","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.3390\/ijms21238984","article-title":"Overcoming Immune Evasion in Melanoma","volume":"21","author":"Eddy","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.111362_b0010","doi-asserted-by":"crossref","unstructured":"L. Filippi, G. Bruno, V. Domazetovic, C. Favre, M. Calvani, Current Therapies and New Targets to Fight Melanoma: A Promising Role for the \u03b23-Adrenoreceptor, Cancers (Basel) 12(6) (2020).","DOI":"10.3390\/cancers12061415"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neo.2021.11.013","article-title":"Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: Results from the 2019 global burden of disease study","volume":"24","author":"Li","year":"2022","journal-title":"Neoplasia"},{"issue":"9687","key":"10.1016\/j.intimp.2023.111362_b0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(09)61397-0","article-title":"Cutaneous melanoma in the era of molecular profiling","volume":"374","author":"Thompson","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/14740338.2016.1248402","article-title":"The safety of anti PD-1 therapeutics for the treatment of melanoma","volume":"16","author":"Ramelyte","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ymthe.2019.02.011","article-title":"Adipocytes: A Novel Target for IL-15\/IL-15R\u03b1 Cancer Gene Therapy","volume":"27","author":"Xiao","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2023.111362_b0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2021.11.022","article-title":"Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis","volume":"162","author":"Goldinger","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10456-017-9593-2","article-title":"Chronic mild hypoxia promotes profound vascular remodeling in spinal cord blood vessels, preferentially in white matter, via an \u03b15\u03b21 integrin-mediated mechanism","volume":"21","author":"Halder","year":"2018","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0045","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/cas.13570","article-title":"Activation of AMPK by simvastatin inhibited breast tumor angiogenesis via impeding HIF-1\u03b1-induced pro-angiogenic factor","volume":"109","author":"Wang","year":"2018","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052777","article-title":"Del Bufalo, Bcl-xL: A Focus on Melanoma Pathobiology","volume":"22","author":"Lucian\u00f2","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.111362_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174021","article-title":"Angiopoietin inhibitors: A review on targeting tumor angiogenesis","volume":"899","author":"Parmar","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0060","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yexcr.2015.06.012","article-title":"Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment","volume":"336","author":"Alahuhta","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.4952","article-title":"Endostatin sensitizes p53-deficient non-small-cell lung cancer to genotoxic chemotherapy by targeting DNA-dependent protein kinase catalytic subunit","volume":"243","author":"Jia","year":"2017","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2023.111362_b0080","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/fon-2021-1239","article-title":"Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer","volume":"18","author":"Zhu","year":"2022","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111362_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030718","article-title":"Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies","volume":"11","author":"M\u00e9ndez-Vald\u00e9s","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13283","article-title":"Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma","volume":"197","author":"Nyakas","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2023.111362_b0095","doi-asserted-by":"crossref","first-page":"1028647","DOI":"10.3389\/fphar.2022.1028647","article-title":"The role of angiogenesis in melanoma: Clinical treatments and future expectations","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10637-021-01172-9","article-title":"Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world data","volume":"40","author":"Zhang","year":"2022","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.intimp.2023.111362_b0105","doi-asserted-by":"crossref","unstructured":"R.D. Schreiber, L.J. Old, M.J. Smyth, Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion, Science (New York, N.Y.) 331(6024) (2011) 1565-70.","DOI":"10.1126\/science.1203486"},{"issue":"12","key":"10.1016\/j.intimp.2023.111362_b0110","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/ni.2762","article-title":"A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application","volume":"14","author":"Okazaki","year":"2013","journal-title":"Nat. Immunol."},{"issue":"26","key":"10.1016\/j.intimp.2023.111362_b0115","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.intimp.2023.111362_b0120","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.intimp.2023.111362_b0125","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1158\/1078-0432.CCR-15-2839","article-title":"Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma","volume":"22","author":"Choueiri","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cam4.106","article-title":"PD-1 as a potential target in cancer therapy","volume":"2","author":"McDermott","year":"2013","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.111362_b0140","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.111362_b0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.molmed.2016.04.008","article-title":"Learning from PD-1 Resistance: New Combination Strategies","volume":"22","author":"Bu","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"648","key":"10.1016\/j.intimp.2023.111362_b0150","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay8690","article-title":"The hallmarks of cancer are also the hallmarks of wound healing","volume":"13","author":"MacCarthy-Morrogh","year":"2020","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40883-019-00113-6","article-title":"Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment","volume":"6","author":"Parayath","year":"2020","journal-title":"Regener. Eng. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tibtech.2005.12.002","article-title":"Cancer gene-therapy: clinical trials","volume":"24","author":"Palmer","year":"2006","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111362_b0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.cgt.7700892","article-title":"Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells","volume":"13","author":"Irie","year":"2006","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/MB:13:1:21","article-title":"Therapeutic genes for cancer gene therapy","volume":"13","author":"Walther","year":"1999","journal-title":"Mol. Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111362_b0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41419-019-1418-3","article-title":"PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112090","article-title":"Periostin deficiency reduces PD-1(+) tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.intimp.2023.111362_b0185","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.vaccine.2010.11.017","article-title":"A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer","volume":"29","author":"Vendrell","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.111362_b0190","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.biopha.2016.07.042","article-title":"MDA7 combined with targeted attenuated Salmonella vector SL7207\/pBud-VP3 inhibited growth of gastric cancer cells","volume":"83","author":"Cao","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4161\/cc.11.1.18667","article-title":"Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice","volume":"11","author":"Zhao","year":"2012","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0200","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-07-1176","article-title":"Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2023.111362_b0205","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00262-012-1256-y","article-title":"Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma","volume":"61","author":"Jia","year":"2012","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"issue":"7","key":"10.1016\/j.intimp.2023.111362_b0210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/cam4.1096","article-title":"A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis","volume":"6","author":"Zhan","year":"2017","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.111362_b0215","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.intimp.2023.111362_b0220","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0225","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1007\/s00261-022-03796-8","article-title":"Melanoma in pregnancy","volume":"48","author":"Czeyda-Pommersheim","year":"2023","journal-title":"Abdominal Radiology (New York)"},{"key":"10.1016\/j.intimp.2023.111362_b0230","doi-asserted-by":"crossref","unstructured":"P. Sharma, J.P. Allison, The future of immune checkpoint therapy, Science (New York, N.Y.) 348(6230) (2015) 56-61.","DOI":"10.1126\/science.aaa8172"},{"key":"10.1016\/j.intimp.2023.111362_b0235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fcell.2020.00672","article-title":"Resistance Mechanisms of Anti-PD1\/PDL1 Therapy in Solid Tumors","volume":"8","author":"Lei","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111362_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031119","article-title":"Epigenetic Modification of PD-1\/PD-L1-Mediated Cancer Immunotherapy against Melanoma","volume":"23","author":"Nanamori","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.intimp.2023.111362_b0245","doi-asserted-by":"crossref","first-page":"51936","DOI":"10.18632\/oncotarget.17232","article-title":"PD1 signal transduction pathways in T cells","volume":"8","author":"Arasanz","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.intimp.2023.111362_b0250","first-page":"2238","article-title":"Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis, Journal of thoracic oncology: official publication of the International Association for the Study of","volume":"11","author":"Fujita","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.intimp.2023.111362_b0255","doi-asserted-by":"crossref","unstructured":"D. Davar, A.K. Dzutsev, J.A. McCulloch, R.R. Rodrigues, J.M. Chauvin, R.M. Morrison, R.N. Deblasio, C. Menna, Q. Ding, O. Pagliano, B. Zidi, S. Zhang, J.H. Badger, M. Vetizou, A.M. Cole, M.R. Fernandes, S. Prescott, R.G.F. Costa, A.K. Balaji, A. Morgun, I. Vujkovic-Cvijin, H. Wang, A.A. Borhani, M.B. Schwartz, H.M. Dubner, S.J. Ernst, A. Rose, Y.G. Najjar, Y. Belkaid, J.M. Kirkwood, G. Trinchieri, H.M. Zarour, Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients, Science (New York, N.Y.) 371(6529) (2021) 595-602.","DOI":"10.1126\/science.abf3363"},{"issue":"6","key":"10.1016\/j.intimp.2023.111362_b0260","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-017-0683-y","article-title":"Nano-based delivery of RNAi in cancer therapy","volume":"16","author":"Xin","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2023.111362_b0275","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2023.111362_b0280","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.3389\/fimmu.2018.03081","article-title":"Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer","volume":"9","author":"Georganaki","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111362_b0285","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.intimp.2023.111362_b0290","first-page":"5709","article-title":"sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients, Clinical cancer research: an official journal of the American Association for","volume":"26","author":"Fane","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2023.111362_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108211","article-title":"The roles of TGF-\u03b2 and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors","volume":"240","author":"Bu","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051089","article-title":"Scientific Rationale for Combined Immunotherapy with PD-1\/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma","volume":"12","author":"Kudo","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.intimp.2023.111362_b0305","first-page":"877","article-title":"Effect of endostatin on proliferation, invasion and epithelial-mesenchymal transition of basal cell carcinoma cell A431","volume":"23","author":"Hu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0310","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1186\/s12885-018-4738-2","article-title":"Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma","volume":"18","author":"Qin","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0315","doi-asserted-by":"crossref","first-page":"e0191040","DOI":"10.1371\/journal.pone.0191040","article-title":"VEGF may contribute to macrophage recruitment and M2 polarization in the decidua","volume":"13","author":"Wheeler","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2023.111362_b0320","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12967-022-03686-z","article-title":"Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.intimp.2023.111362_b0325","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2023.111362_b0330","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","article-title":"An HIF-1\u03b1\/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression","volume":"32","author":"Palazon","year":"2017","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.intimp.2023.111362_b0335","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2023.111362_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109022","article-title":"A review of PD-1\/PD-L1 siRNA delivery systems in immune T cells and cancer cells","volume":"111","author":"Barati","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2023.111362_b0345","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1016\/j.apsb.2022.05.006","article-title":"Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhi murium VNP20009 in anti-PD1 therapy against melanoma","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:10:06Z","timestamp":1761588606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923016892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":69,"alternative-id":["S1567576923016892"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111362","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmid co-expressing siRNA-PD-1 and Endostatin carried by attenuated Salmonella enhanced the anti-melanoma effect via inhibiting the expression of PD-1 and VEGF on tumor-bearing mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111362"}}